artesunic acid has been researched along with Parasitemia in 146 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (7.53) | 18.2507 |
| 2000's | 55 (37.67) | 29.6817 |
| 2010's | 67 (45.89) | 24.3611 |
| 2020's | 13 (8.90) | 2.80 |
| Authors | Studies |
|---|---|
| Good, GM; Oraebosi, MI | 1 |
| Oraebosi, MI | 1 |
| Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM | 1 |
| Cherkaoui-Rbati, MH; Davenport, MP; Demarta-Gatsi, C; Gobeau, N; Gower, J; Gumpp, C; Khoury, DS; McCarthy, JS; Möhrle, JJ; Radohery, GFR; Rebelo, M; Rottmann, M; Walz, A | 1 |
| Arama, C; Beavogui, AH; Dicko, A; Djimde, A; Djimde, M; Fofana, B; Kayentao, K; Mens, PF; Ouedraogo, JB; Sagara, I; Schallig, HD; Sirima, SB; Tshiongo, JK | 1 |
| Alberer, M; Bélard, S; Blohm, M; Brand, J; Gratopp, A; Hübner, J; Hufnagel, M; Janda, A; Kempf, C; Kobbe, R; Krüger, R; Kurth, F; Mall, M; Reiter, K; Schulze-Sturm, U; Stegemann, MS; Suttorp, N; Tacoli, C; Varnholt, V; von Bernuth, H; von Both, U; Zoller, T | 1 |
| Addo, MM; Adegnika, AA; Agbenyega, T; Ansong, D; Cramer, JP; Fürst, S; Jacobs, T; Kremsner, PG; Kurth, F; May, J; Ramharter, M; Rolling, T; Scheu, K; Sylverken, J; Vinnemeier, CD | 1 |
| Beshir, KB; Coulibaly, A; Dembele, D; Diallo, N; Djimde, AA; Doumbo, OK; Fofana, B; Gil, JP; Haidara, AS; Haidara, K; Kone, A; Sagara, I; Sangare, CO; Sanogo, K; Sissoko, S; Toure, S; Traore, A | 1 |
| Friedman, A; Siewe, N | 1 |
| Bitam, I; Davoust, B; Hamidat, HK; Lafri, I; Laidoudi, Y; Lounas, A; Mediannikov, O; Medkour, H; Mekroud, A; Varloud, M | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Feng, XX; He, WH; Li, YY; Wu, X; Yao, DW; Zhai, XH; Zhang, B | 1 |
| Abraham, P; Argaud, L; Becker, A; Bienvenu, AL; Bonnot, G; Chidiac, C; Conrad, A; Kouakou, YI; Landre, S; Leboucher, G; Miailhes, P; Picot, S; Rimmelé, T; Simon, M | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Adamo, G; Ascoli Bartoli, T; Bevilacqua, N; Buffet, P; Corpolongo, A; D'Abramo, A; Giancola, ML; Ippolito, G; Lepore, L; Mariano, A; Nicastri, E; Palazzolo, C; Scorzolini, L | 1 |
| Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
| Kimani, FT; Kirira, PG; Magoma, GN; Malala, BJ; Muregi, FW; Odhiambo, OC; Wamakima, HN | 1 |
| Akter, J; Aogo, RA; Best, SE; Cromer, D; Davenport, MP; Elliott, T; Engel, JA; Gartlan, KH; Haque, A; James, KR; Khoury, DS; Sebina, I; Soon, MSF; Thomas, BS | 1 |
| Bhadauria, D; Gupta, A; Jain, M; Kaul, A; Prasad, N; Sharma, RK; Vardhan, H | 1 |
| Bani-Sadr, F; Brunet, A; Cousson, J; Floch, T; Giltat, A; Julien, G; Lebrun, D; N'Guyen, Y; Romaru, J; Toubas, D | 1 |
| Balani, B; Feldman, J; Hewitt, K; Parrish, A; Procopio, G; Zodda, D | 1 |
| Anstey, NM; Barber, BE; Chandna, A; Drakeley, CJ; Grigg, MJ; Menon, J; Patel, K; Piera, K; Rajahram, GS; Schimann, E; Wilkes, CS; William, T; Yeo, TW | 1 |
| Aung, AA; Bancone, G; Carrara, VI; Cheah, PY; Chu, CS; Chue, AL; Imwong, M; Lwin, KM; Moore, KA; Nosten, F; Phyo, AP; Proux, S; Raksapraidee, R; San, T; Sriprawat, K; Tarning, J; Watson, J; White, NJ; Wiladphaingern, J; Win, HH; Winterberg, M | 1 |
| Alejo-Cancho, I; Camprubí, D; Cisteró, P; García-Guijarro, E; Gupta, H; Llenas-García, J; Mayor, A; Muñoz, J; Rodríguez-Valero, N | 1 |
| Akter, J; Aogo, RA; Cromer, D; Davenport, MP; Elliott, T; Fogg, LG; Haque, A; Khoury, DS; Laohamonthonkul, P; Liligeto, UN; Nair, AS; Pernold, CPS; Romanczuk, AS; Soon, MSF; Thomas, BS | 1 |
| Byakika-Kibwika, P; Kiragga, AN; Lamorde, M; Nyakato, P | 1 |
| Hastings, IM; Hodel, EM; Jones, S; Kay, K; Sharma, R | 1 |
| Amaratunga, C; Ashley, EA; Ataíde, R; Beeson, JG; Day, NP; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, MA; Feng, G; Fowkes, FJI; Hien, TT; Htut, Y; Lim, P; Mayxay, M; Nosten, F; O'Flaherty, K; Powell, R; Pukrittayakamee, S; Reiling, L; Simpson, JA; White, NJ; Zaloumis, SG | 1 |
| Anderson, JM; Chiang, S; Diakite, M; Diakite, SA; Doumbia, S; Doumbouya, M; Fairhurst, RM; Fay, MP; Keita, AS; Konate, DS; Long, CA; Lopera-Mesa, TM; Ndiaye, D; Sa, JM; Stepniewska, K; Traore, K; Zeituni, AE | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Araújo, N; Coelho, PM; Katz, N; Kusel, JR; Vimieiro, AC | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Anvikar, AR; Dash, AP; Dubhashi, NG; Ghosh, SK; Jullien, V; Kiechel, JR; Kumar, A; Rao, BH; Sharma, B; Singh, JP; Srivastava, B; Taylor, WR; Valecha, N | 1 |
| Chansiripornchai, N; Nithiuthai, S; Sasipreeyajan, J; Sohsuebngarm, D | 1 |
| Kumar, KK; Prasad, DM; Rajyalakshmi, M; Satish, PV; Sowjanya, M; Sunita, K | 1 |
| Abdallah, TM; Adam, I; Desogi, MA; Elhag, MS; Elhassan, AH; Elmardi, KA; Omer, MB; Siddig, MF | 1 |
| Gebru, T; Gerth, K; Held, J; Jansen, R; Kalesse, M; Mordmüller, B; Müller, R | 1 |
| Biligui, S; Buffet, PA; Chiang, S; Ciceron, L; Claessens, A; Diakité, M; Diakité, SA; Fairhurst, RM; Jauréguiberry, S; Kendjo, E; Lopera-Mesa, TM; Mazier, D; Mouri, O; Ndour, PA; Roussel, C; Thellier, M | 1 |
| Buddhirakkul, P; Chumpolbanchorn, K; Harnyuttanakorn, P; Narkpinit, S; Pattaradilokrat, S; Pimnon, S; Pruck-Ngern, M; Saiwichai, T | 1 |
| Bienvenu, AL; Bonnot, G; Bringer, C; Fourier, A; Gagnieu, MC; Lavoignat, A; Marijon, A; Picot, S | 1 |
| Anderson, T; Ashley, EA; Bethell, D; Cooper, BS; Dondorp, AM; Flegg, JA; Lubell, Y; Nair, S; Nguon, C; Nkhoma, S; Nosten, F; Pan-Ngum, W; Phyo, AP; Plowe, C; Silamut, K; Stepniewska, K; Tripura, R; White, LJ; White, NJ; Wiladpai-ngern, JH | 1 |
| Allister, LM; Brown, DF; Miller, ES; Schultz, ML | 1 |
| Anstey, NM; Dondorp, AM; Ghose, A; Haider, MS; Hossain, MA; Kingston, HW; Plewes, K; Turner, GD; Yeo, TW | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Arguin, PM; Kachur, SP; McCarthy, W; McDermott, C; Novitt-Moreno, A; Smith, BL; Twomey, PS | 1 |
| Calvo-Cano, A; Gascón, J; Gómez-Junyent, J; Muñoz, J; Ruiz-Panales, P | 1 |
| Dama, S; Dembele, D; Djimde, AA; Doumbo, OK; Fofana, B; Maiga, AW; Ouologuem, D; Sagara, I; Sanogo, K; Sidibe, B; Toure, S | 1 |
| Bastos, MS; de Melo, GN; de Souza-Lima, Rde C; Ferreira, MU; Ladeia-Andrade, S; Luz, Fd; Rodrigues, PT; Salla, LC | 1 |
| Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
| Dev, AV; Peter, JV; Sathyendra, S; Seshadri, P; Viggeswarpu, S | 1 |
| Arango, E; Blair, S; Carmona-Fonseca, J | 1 |
| Agomo, PU; Aina, OO; Ezeiru, VI; Meremikwu, MM; Odey, FA; Oguche, S; Omalu, IJ; Watila, IM | 1 |
| Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
| Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
| Anders, RF; Beeson, JG; Gilson, PR; King, CL; McCallum, FJ; Michon, P; Mueller, I; Murphy, VJ; Richards, JS; Schoepflin, S; Stanisic, DI | 1 |
| Alifrangis, M; Bousema, T; Gouagna, LC; Howitt, C; Oesterholt, MJ; Omar, SA; Sauerwein, RW; Sawa, P; Sutherland, CJ | 1 |
| Ishih, A; Kano, S; Kino, H; Muregi, FW | 1 |
| Bacon, DJ; Durand, S; Ganguly, B; Green, M; Gutman, J; Quezada, WM; Rojas, OV; Ruebush, TK; Slutsker, L; Utz, GC | 1 |
| Barger, B; Dara, A; Djimde, AA; Doumbo, OK; Gantt, S; Maiga, H; Tekete, M; Tembine, I; Traore, OB; Traore, ZI | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Ahorlu, CK; Koram, KA; Seakey, AK; Weiss, MG | 1 |
| Alvarez, LG; Blair, S; Ríos, A; Sanín, F; Tobón, A; Vásquez, AM | 1 |
| Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C | 1 |
| Akter, J; Haque, R; Khan, WA; Ley, B; Marma, AS; Noedl, H; Starzengruber, P; Swoboda, P; Thriemer, K; Vossen, MG | 1 |
| Biggs, BA; Casey, GJ; Cowman, AF; Hung, NM; Phuc, BQ; Thanh, NV; Tien, NT; Toan, TQ | 1 |
| Duangdee, C; Krudsood, S; Looareesuwan, S; Pothipak, N; Tangpukdee, N; Warrell, DA; Wilairatana, P | 1 |
| Alvarez, G; Blair, S; Piñeros, JG; Ríos, A; Tobón, A | 1 |
| Bartalesi, F; Bartoloni, A; Castelli, F; Galli, L; Pini, A; Sani, S; Tomasoni, L; Veloci, S; Zammarchi, L | 1 |
| Carvalho, LJ; Clemmer, L; Frangos, JA; Martins, YC; Zanini, GM | 1 |
| Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
| Cochupanachimootil, J; Harris, P; Norton, R; Price, S; Senthuran, S | 1 |
| Alemu, H; Anbessie, J; Diro, E; Mao, P; Pinchouk, N; Seboxa, T | 1 |
| Obaro, SK | 1 |
| Na-Bangchang, K; Ruengweerayut, R; Wernsdorfer, WH | 1 |
| Bethell, D; Darapiseth, S; Fukuda, MM; Gosi, P; Khemawoot, P; Kuntawungin, W; Lin, J; Lon, C; Ruttvisutinunt, W; Saunders, D; Schaecher, K; Se, Y; Smith, B; Socheat, D; Sriwichai, S; Teja-Isavadharm, P; Timmermans, A; Tyner, S | 1 |
| Akanbi, OM; Cyril-Olutayo, CM; Fasimoye, RY; Omonkhua, AA | 1 |
| Anstey, NM; Chan, L; Donaldson, S; Frederick, C; Jelip, J; Khoo, S; Ma, G; Menon, J; Rajahram, G; William, T; Yeo, TW | 1 |
| Bousema, T; Drakeley, C; Gosling, R; Hermsen, R; Masokoto, A; Mosha, F; Mwanziva, C; Okell, L; Sauerwein, R; Semvua, S; Shekalaghe, SA; Teelen, K; ter Braak, R; van den Bijllaardt, W; van den Bosch, S | 1 |
| Flegg, JA; Guerin, PJ; Stepniewska, K; White, NJ | 1 |
| Bassene, C; Bygbjerg, IC; Faye, B; Gaye, O; Magnussen, P; Ndiaye, JL; Ndiaye, M; Ndour, CT; Ndour, JD; Sylla, K; Tine, RC | 1 |
| Bouyou Akotet, MK; Chimalizeni, Y; Duparc, S; Duscha, M; Humberg, A; Issifou, S; Kawaza, K; Köhler, C; Kombila, M; Kösters, K; Kremsner, PG; Krishna, S; Kun, JF; Miller, RS; Möhrle, J; Mordmüller, B; Planche, T; Simpson, JA; Taylor, T; Teja-Isavadharm, P; Weina, P | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Burchard, GD; Cramer, JP; Rolling, T; Schmiedel, S; Wichmann, D; Wittkopf, D | 1 |
| Chatterjee, SK; Das, BK; Guh, P; Mandal, B; Ray, A; Shai, S; Sharma, A | 1 |
| Dama, S; Dara, A; Dembele, D; Djimde, AA; Doumbo, OK; Fofana, B; Kone, A; Maiga, AW; Plowe, CV; Sagara, I; Sanogo, K; Sidibe, B; Thera, MA; Toure, S; Traore, OB | 1 |
| Bethell, D; Chanthap, L; Fukuda, M; Khemawoot, P; Lin, J; Noedl, H; Ringwald, P; Rutvisuttinunt, W; Saunders, D; Se, Y; Siripokasupkul, R; Smith, B; Socheat, D; Sriwichai, S; Teja-Isavadharm, P; Timmermans, A; Tyner, S; Vanachayangkul, P | 1 |
| Joshi, M; Pathak, S; Patil, S; Patravale, V; Sharma, S | 1 |
| Amos, B; Chotivanich, K; Day, NP; Dondorp, AM; Fanello, CI; Gesase, S; Gomes, E; Hendriksen, IC; Joseph, S; Karema, C; Lee, SJ; Maitland, K; Mtove, G; Mwanga-Amumpaire, J; Olaosebikan, R; Pan-Ngum, W; Reyburn, H; Saiwaew, S; Silamut, K; Tshefu, AK; von Seidlein, L; White, LJ; White, NJ; Woodrow, C | 1 |
| Alker, AP; MacArthur, JR; Meshnick, SR; Satimai, W; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Anstey, NM; Auburn, S; Barber, BE; Grigg, MJ; Marfurt, J; Menon, J; William, T; Yeo, TW | 1 |
| Dondorp, AM | 1 |
| Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Imwong, M; Lee, SJ; Lindegardh, N; Lwin, KM; Menard, D; Nguon, C; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Socheat, D; Stepniewska, K; Tarning, J; Tripura, R; White, NJ; Yi, P | 1 |
| Cravo, P; Henriques, G; Rodrigues, L | 1 |
| Dow, GS; Kyle, DE; Lee, P; Li, QG; Si, YZ; Wong, E; Xie, LH | 1 |
| Cabezas, C; Calampa, C; Falconí, E; Huilca, M; Marquiño, W; Naupay, R; Ruebush, TK | 1 |
| Chaikachonpatd, S; Chanthapakajee, K; Chindarat, S; Kaewkaukul, N; Lim, K; Silpasakorn, S; Suputtamongkol, Y; Thamlikitkul, V | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Coleman, R; Drakeley, CJ; Jawara, M; Obisike, U; Pinder, M; Sutherland, CJ; Targett, GA; Walraven, G | 1 |
| Avila, JC; Marquiño, W; Mollinedo, R; Ruebush, TK; Villaroel, R; Zegarra, J | 1 |
| Barennes, H; Koussoubé-Balima, T; Nagot, N; Ouedraogo, A; Sanou, T; Valea, I; Yé, S | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Peters, W; Robinson, BL; Stewart, LB | 2 |
| Havlik, I; Kaneko, Y; Kozbor, D; Krudsood, S; Looareesuwan, S; Thuma, PE; Vannaphan, S; Watanabe, N; Wilairatana, P | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI; Idris, SM; Malik, EM | 1 |
| Ashley, EA; Barends, M; Cho, T; Hutagalung, R; Looareesuwan, S; McGready, R; Moo, E; Nosten, F; White, NJ | 1 |
| Adegnika, AA; Altun, H; Gläser, B; Grobusch, MP; Issifou, S; Klein Klouwenberg, P; Kremsner, PG; Kun, JF; Oyakhirome, S; Pötschke, M; Schwarz, NG | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Arbe-Barnes, S; Brun, R; Kocken, CH; Matile, H; Scheurer, C; Thomas, AW; van der Wel, A; Wittlin, S | 1 |
| Chiswell, GM; Dabod, E; Davis, TM; Hamzah, J; Ilett, KF; Karunajeewa, HA; Lorry, K; Page-Sharp, M; Reeder, J | 1 |
| Bousema, T; Gouagna, L; Omar, S; Sauerwein, R; Sawa, P; Schallig, H; Schneider, P | 1 |
| Li, Q; Lin, AJ; Skillman, DS; Smith, K; Xie, LH; Zhang, J | 1 |
| Balkan, S; Checchi, F; Durand, R; Grandesso, F; Guthmann, JP; Hagerman, A; Kamara, S; Lam, E; Scollo, G | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Adjuik, M; Beck, HP; Mshinda, H; Mugittu, K; Ntoumi, F; Olliaro, P; Snounou, G; Taylor, W | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Agbenyega, T; Barnes, KI; Di Perri, G; Folb, P; Gomes, M; Krishna, S; Krudsood, S; Looareesuwan, S; Mansor, S; McIlleron, H; Miller, R; Molyneux, M; Mwenechanya, J; Navaratnam, V; Nosten, F; Olliaro, P; Pang, L; Ribeiro, I; Simpson, JA; Tembo, M; van Vugt, M; Ward, S; Weerasuriya, K; White, NJ; Win, K | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Ibrahium, AM; Khalil, IF; Kheir, MM; Malik, EM; Osman, ME | 1 |
| Adjuik, M; Beck, HP; Guthmann, JP; Kiguli, J; Mshinda, H; Mugittu, K; Olliaro, PL; Priotto, G; Snounou, G; Taylor, WR | 1 |
| Gonzalez, I; Olliaro, P; Osorio, L; Taylor, WR | 1 |
| Cao, YM; Chen, G; Feng, H; Guo, SY; Li, DM; Liu, YJ; Ma, SH; Wang, JC; Zheng, L | 1 |
| Clark, TD; Dokomajilar, C; Dorsey, G; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, S | 1 |
| Beeson, JG; Cole-Tobian, JL; Dabod, E; Igu, J; King, CL; Michon, P; Mueller, I; Reeder, JC; Schoepflin, S; Schofield, L; Susapu, M; Tarongka, N; Zimmerman, PA | 1 |
| Cole-Tobian, JL; Dabod, E; King, CL; Michon, P; Mueller, I | 1 |
| Brasseur, P; Cisse, M; Diouf, AM; Faye, B; Gaye, O; Kuété, T; Lameyre, V; Ndiaye, JL; Same-Ekobo, A; Seck, PA | 1 |
| Ashley, EA; Lwin, KM; McGready, R; Nosten, F; Proux, S; Silamut, K | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Raimond, SD; White, NJ | 1 |
| Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
| Boulard, Y; Caillard, V; Fleck, SL; Glénat, C; Landau, I; Peters, W; Robinson, BL; Thévin, F | 1 |
| Attanath, P; Brewer, TG; Chanthavanich, P; Chongsuphajaisiddhi, T; Heppner, DG; Mookmanee, D; Phanuaksook, P; Poonpanich, Y; Prarinyanupharb, V; Sabchareon, A; Teja-Isavadharm, P | 1 |
| Graninger, W; Looareesuwan, S; Parschalk, B; Vannapann, S; Wanaratana, V; Wenisch, C; Wernsdorfer, W; Wilairatana, P | 1 |
| Benakis, A; Halpaap, B; Kremsner, PG; Ndjave, M; Paris, M | 1 |
| Chongsuphajaisiddhi, T; Looareesuwan, S; Viriyavejakul, P; Wilairatana, P | 1 |
| Batty, KT; Davis, TM; Huynh, VT; Ilett, KF; Le, AT; Nguyen, CH; Nguyen, PT; Nguyen, VM; Powell, SM; Tran, QB; Truong, XM; Vuong, VC | 1 |
| Hills, F; Krudsood, S; Looareesuwan, S; Porter, RS; Sjostrom, L; Warrell, DA; Wilairatana, P | 1 |
| Ducret, JP; Essono, E; Lohoue, J; Ravinet, L; Same-Ekobo, A | 1 |
| Alloueche, A; Anyalebechi, C; Bojang, K; Coleman, R; Doherty, T; Duraisingh, M; Gosling, R; Greenwood, B; McAdam, K; Milligan, P; Olliaro, P; Pinder, M; Sadiq, A; Targett, G; Ude, JI; von Seidlein, L; Walraven, G; Warhurst, D | 1 |
| Bussaratid, V; Krudsood, S; Looareesuwan, S; Phumratanaprapin, W; Silachamroon, U; Singhasivanon, P; Srivilirit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
| Angus, B; Chotivanich, K; Dondorp, A; Looareesuwan, S; Newbold, CI; Pukrittayakamee, S; Simpson, JA; Udomsangpetch, R; White, NJ; Williams, T | 1 |
| Ginsburg, H; Hoshen, MB; Na-Bangchang, K; Stein, WD | 1 |
| Coleman, R; Doherty, T; Jawara, M; Targett, G; von Seidlein, L; Walraven, G | 1 |
| Anstey, NM; Currie, BJ; Morris, PS; Saunders, JR; Suprianto, S; Tjitra, E | 1 |
| Anh, CV; Davis, TM; Giang, LT; Hang, NT; Hewitt, S; Quang, HH; Thoa, NT; Thuan, LK; Thuy, PT; Trung, TN; Tuan, NT | 1 |
| Ginsburg, H; Hoshen, MB; Stein, WD | 1 |
| Chotivanich, K; Looareesuwan, S; McGready, R; Newton, P; Proux, S; Pukrittayakamee, S; Udomsangpetch, R; White, NJ | 1 |
7 review(s) available for artesunic acid and Parasitemia
| Article | Year |
|---|---|
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis.
Topics: Adult; Antimalarials; Artesunate; Coombs Test; Female; Hemolysis; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Parasitemia; Young Adult | 2021 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Acute pancreatitis and subdural haematoma in a patient with severe falciparum malaria: case report and review of literature.
Topics: Adult; Animals; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Blood; Brain; Doxycycline; Hematoma, Subdural; Humans; Malaria, Falciparum; Male; Pancreatitis; Parasitemia; Plasmodium falciparum; Quinine; Radiography; Sesquiterpenes | 2008 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Rural Health; Sesquiterpenes; Suppositories | 1997 |
57 trial(s) available for artesunic acid and Parasitemia
| Article | Year |
|---|---|
Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Artesunate; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Parasite Load; Parasitemia; Zoonoses | 2020 |
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
Topics: Adolescent; Adult; Antimalarials; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Vivax; Male; Middle Aged; Myanmar; Parasitemia; Plasmodium vivax; Primaquine; Recurrence; Thailand; Treatment Outcome; Young Adult | 2018 |
Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
Topics: Administration, Intravenous; Antimalarials; Artesunate; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Uganda | 2018 |
Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
Topics: Adolescent; Adult; Aged; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Artesunate; Child; Child, Preschool; Drug Resistance, Microbial; Erythrocytes; Female; Humans; Immunity, Innate; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Merozoites; Middle Aged; Parasitemia; Phagocytosis; Plasmodium falciparum; Protozoan Proteins; Seroepidemiologic Studies; Treatment Outcome; Young Adult | 2019 |
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Demography; Drug Therapy, Combination; Endemic Diseases; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2013 |
The efficacy of artesunate, chloroquine, doxycycline, primaquine and a combination of artesunate and primaquine against avian malaria in broilers.
Topics: Analysis of Variance; Animals; Antimalarials; Artemisinins; Artesunate; Body Weight; Chickens; Chloroquine; Doxycycline; Drug Combinations; Malaria, Avian; Parasitemia; Poultry Diseases; Primaquine; Treatment Outcome | 2014 |
Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Coma; Female; Hospitals; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Quinine; Sudan; Treatment Outcome; Young Adult | 2014 |
Efficacy of intranasal administration of artesunate in experimental cerebral malaria.
Topics: Administration, Intranasal; Animals; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Brain Chemistry; Disease Models, Animal; Female; Malaria, Cerebral; Mice, Inbred CBA; Parasitemia; Placebos; Random Allocation; Single-Blind Method; Survival Analysis; Treatment Outcome | 2014 |
Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Resistance; Female; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mali; Parasitemia; Plasmodium falciparum; Prospective Studies; Single-Blind Method | 2016 |
No Clinical or Molecular Evidence of Plasmodium falciparum Resistance to Artesunate-Mefloquine in Northwestern Brazil.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Combinations; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2016 |
[Gametocytemia in falciparum malaria treated with amodiaquine or artesunate].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Rural Population; Time Factors | 2008 |
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
Topics: Animals; Artemisinins; Artesunate; Carrier State; Child, Preschool; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Germ Cells; Humans; Infant; Kenya; Malaria, Falciparum; Mutation; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Plasmodium falciparum; Time Factors; Treatment Outcome; Young Adult | 2009 |
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.
Topics: Adolescent; Anemia; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mali; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Caregivers; Child, Preschool; Drug Administration Schedule; Female; Fever; Ghana; Humans; Infant; Malaria; Male; Parasitemia; Plasmodium falciparum; Prevalence; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2009 |
[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Female; Fever; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Pilot Projects; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2009 |
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Bangladesh; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Time Factors; Treatment Outcome; Young Adult | 2010 |
Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Therapy, Combination; Fever; Humans; Ibuprofen; Injections, Intravenous; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2010 |
Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial.
Topics: Adolescent; Adult; Amebicides; Antimalarials; Artemisinins; Artesunate; Cambodia; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Malaria; Male; Maximum Tolerated Dose; Neutropenia; Parasitemia; Young Adult | 2011 |
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Infant; Malaria; Male; Microscopy; Middle Aged; Parasitemia; Placebos; Primaquine; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2011 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Community Health Workers; Disease Management; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Health Promotion; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prevalence; Preventive Health Services; Pyrimethamine; Rural Population; Seasons; Senegal; Sulfadoxine | 2011 |
A simplified intravenous artesunate regimen for severe malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Parasite Load; Parasitemia; Time Factors; Treatment Outcome | 2012 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Severity of Illness Index | 2012 |
Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement.
Topics: Adolescent; Africa; Antigens, Protozoan; Artemisinins; Artesunate; Child; Child, Preschool; Demography; Female; Humans; Infant; Malaria, Falciparum; Male; Models, Biological; Odds Ratio; Parasitemia; Prospective Studies; Protozoan Proteins; Quinine; Risk Factors; Severity of Illness Index | 2012 |
Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Drug Resistance; Female; Half-Life; Humans; Immunoglobulin G; Malaria, Falciparum; Male; Parasite Load; Parasitemia; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2013 |
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Recurrence; Sesquiterpenes; Treatment Outcome; Vomiting | 2003 |
The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Primaquine; Secondary Prevention; Sesquiterpenes | 2003 |
Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes.
Topics: Acute Disease; Age Factors; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Prevalence; Sesquiterpenes; Treatment Failure | 2004 |
Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Bolivia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; beta-Glucans; Child; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2005 |
Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Sudan; Treatment Outcome | 2005 |
A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Naphthoquinones; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proguanil; Quinine; Sesquiterpenes; Thailand | 2005 |
5-day nonobserved artesunate monotherapy for treating uncomplicated Falciparum malaria in young Gabonese children.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Endemic Diseases; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Papua New Guinea; Parasitemia; Retrospective Studies; Sesquiterpenes; Severity of Illness Index; Suppositories | 2006 |
(Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nucleic Acid Amplification Techniques; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitemia; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2007 |
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Uganda | 2007 |
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Colombia; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2007 |
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda; Urban Population | 2007 |
Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Female; Gastrointestinal Diseases; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Pruritus; Senegal; Sesquiterpenes | 2008 |
Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinine; Sesquiterpenes; Time Factors; Treatment Outcome | 1995 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Pilot Projects; Recurrence; Sesquiterpenes; Suppositories; Thailand | 1998 |
Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cytokines; Drug Therapy, Combination; Fever; Humans; Interleukin-6; Malaria, Falciparum; Parasitemia; Pentoxifylline; Phosphodiesterase Inhibitors; Receptors, Interleukin-6; Receptors, Tumor Necrosis Factor; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1998 |
A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Biological Availability; Cross-Over Studies; Half-Life; Humans; Injections, Intravenous; Malaria, Vivax; Male; Parasitemia; Plasmodium vivax; Sesquiterpenes; Vietnam | 1998 |
[Rapid resolution of Plasmodium ovale malarial attacks using artesunate (Arsumax)].
Topics: Acute Disease; Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Cameroon; Fever; Humans; Malaria; Middle Aged; Parasitemia; Plasmodium; Reticulocytes; Sesquiterpenes; Time Factors; Vertigo | 1999 |
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1999 |
Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Indonesia; Infant; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Risk; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Failure; Treatment Outcome | 2001 |
Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Recurrence; Regression Analysis; Sesquiterpenes; Statistics, Nonparametric; Vietnam | 2001 |
82 other study(ies) available for artesunic acid and Parasitemia
| Article | Year |
|---|---|
Carica papaya augments anti-malarial efficacy of artesunate in Plasmodium berghei parasitized mice.
Topics: Animals; Antimalarials; Artesunate; Carica; Mice; Parasitemia; Plasmodium berghei | 2021 |
Beneficial interaction between Ficus platyphylla and artesunate on cytokines TNF-α and IL-10 and oxidative stress in Plasmodium berghei-infected mice.
Topics: Animals; Antimalarials; Artesunate; Cytokines; Drug Combinations; Ficus; Interleukin-10; Malaria; Mice; Oxidative Stress; Parasitemia; Plasmodium berghei; Transferases; Tumor Necrosis Factor-alpha | 2022 |
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence | 2022 |
Parasite Viability as a Measure of
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Australia; Humans; Malaria, Falciparum; Mice; Parasitemia; Parasites; Plasmodium falciparum | 2022 |
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
Topics: Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Neutropenia; Neutrophils; Parasitemia; Plasmodium falciparum; Prospective Studies | 2023 |
Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Antimalarials; Artesunate; Child; Child, Preschool; Communicable Diseases, Imported; Female; Germany; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Retrospective Studies; Tertiary Care Centers | 2019 |
Determinants of post-malarial anemia in African children treated with parenteral artesunate.
Topics: Anemia; Antimalarials; Artesunate; Blood Transfusion; Child; Child, Preschool; Erythropoietin; Female; Humans; Infant; Infusions, Parenteral; Malaria; Male; Parasitemia | 2019 |
Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy.
Topics: Antimalarials; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Mali; Microscopy; Parasitemia; Plasmodium falciparum; Real-Time Polymerase Chain Reaction | 2020 |
Increase hemoglobin level in severe malarial anemia while controlling parasitemia: A mathematical model.
Topics: Anemia; Animals; Antimalarials; Artesunate; Computer Simulation; Dendritic Cells; Drug Therapy, Combination; Erythrocytes; Hemoglobins; Humans; Intramolecular Oxidoreductases; Limonins; Macrophage Activation; Macrophage Migration-Inhibitory Factors; Malaria, Falciparum; Mathematical Concepts; Mice; Models, Biological; Models, Immunological; Parasitemia; Th1 Cells | 2020 |
Evaluation of the inhibitory effects of drugs on the growth of Babesia gibsoni using relative quantification real-time PCR.
Topics: Animals; Antiprotozoal Agents; Artesunate; Babesia; Diminazene; Drug Resistance; Erythrocytes; Parasitemia; Parasitic Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 18S | 2020 |
Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy.
Topics: Aged; Antimalarials; Artesunate; Humans; Malaria, Falciparum; Male; Parasitemia; Recurrence | 2021 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Blood-Brain Barrier; Disease Models, Animal; Drug Evaluation; Heterocyclic Compounds; Malaria, Cerebral; Male; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium berghei; Quinine; Quinolines; Random Allocation; Safety | 2017 |
Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Topics: Adoptive Transfer; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Erythrocytes; Female; Flow Cytometry; Malaria; Mefloquine; Mice; Mice, Inbred C57BL; Parasitemia; Phagocytes; Plasmodium berghei; Plasmodium yoelii | 2017 |
P. vivax Malaria presenting as Thrombotic Microangiopathy.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Vivax; Male; Parasitemia; Plasmapheresis; Renal Dialysis; Retrospective Studies; Thrombotic Microangiopathies; Young Adult | 2017 |
Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Adult; Anemia, Hemolytic; Artemisinins; Artesunate; Coombs Test; Hemolysis; Humans; Malaria, Falciparum; Male; Parasitemia; Travel | 2018 |
Severe malaria presenting to the ED: A collaborative approach utilizing exchange transfusion and artesunate.
Topics: Adult; Antimalarials; Artesunate; Critical Care; Emergency Medical Services; Exchange Transfusion, Whole Blood; Humans; Infectious Disease Medicine; Intersectoral Collaboration; Malaria, Cerebral; Male; Parasitemia; Severity of Illness Index; Treatment Outcome | 2018 |
Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.
Topics: Acute Kidney Injury; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kidney; Malaria; Malaysia; Male; Parasitemia; Plasmodium knowlesi; Prospective Studies; Severity of Illness Index | 2018 |
Suspected quinine resistant P. falciparum severe malaria possibly acquired in Ivory Coast.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Clindamycin; Cote d'Ivoire; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Parasitemia; Quinine; Spain; Treatment Failure; Treatment Outcome | 2018 |
Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice.
Topics: Animals; Antimalarials; Artesunate; Blood; Disease Models, Animal; Fluorescence; Malaria; Mefloquine; Mice; Models, Theoretical; Organisms, Genetically Modified; Parasite Load; Parasitemia; Plasmodium berghei; Staining and Labeling | 2018 |
Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Models, Biological; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2019 |
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Topics: Adaptive Immunity; Adolescent; Amodiaquine; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Erythrocytes; Female; Humans; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Mali; Parasite Load; Parasitemia; Plasmodium falciparum | 2013 |
Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection.
Topics: Animals; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Mice; Oxamniquine; Parasite Egg Count; Parasitemia; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2013 |
Human malaria in C57BL/6J mice: an in vivo model for chemotherapy studies.
Topics: Animals; Artemisinins; Artesunate; Disease Models, Animal; Drug Resistance, Multiple; Female; Humans; Malaria; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium falciparum | 2014 |
Antimalarial activity of the myxobacterial macrolide chlorotonil a.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Hydrocarbons, Chlorinated; Macrolides; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Myxococcales; Parasitemia; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2014 |
Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Parasite Load; Parasitemia; Plasmodium falciparum; Retrospective Studies; Treatment Outcome | 2015 |
Effects of artesunate treatment on Plasmodium gallinaceum transmission in the vectors Aedes aegypti and Culex quinquefasciatus.
Topics: Aedes; Animals; Antimalarials; Artemisinins; Artesunate; Chickens; Culex; Female; Insect Vectors; Malaria, Avian; Parasitemia; Plasmodium gallinaceum; Time Factors | 2015 |
Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Life Cycle Stages; Malaria, Falciparum; Myanmar; Parasite Load; Parasitemia; Phenotype; Phylogeny; Plasmodium falciparum; Reference Values; Thailand | 2015 |
Altered Mental Status and Fever.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Ceftriaxone; Child; Confusion; Drug Therapy, Combination; Emergency Service, Hospital; Exchange Transfusion, Whole Blood; Female; Fever; Ghana; Humans; Malaria, Cerebral; Massachusetts; Parasitemia; Travel; Vancomycin | 2015 |
Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury.
Topics: Acute Kidney Injury; Administration, Intravenous; Anemia, Hemolytic; Artemisinins; Artesunate; Bangladesh; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Treatment Outcome | 2015 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Drugs, Investigational; Female; Humans; Infant; Injections, Intravenous; Malaria; Male; Medication Adherence; Middle Aged; Parasitemia; Retrospective Studies; Treatment Outcome; United States; Young Adult | 2015 |
Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum.
Topics: Adult; Africa South of the Sahara; Anemia, Hemolytic; Antimalarials; Artesunate; Biomarkers; Emigrants and Immigrants; Female; Humans; Incidence; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Retrospective Studies; Senegal; Time Factors; Travel-Related Illness | 2017 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Topics: Adolescent; Age Factors; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Malaria, Falciparum; Membrane Proteins; Merozoite Surface Protein 1; Merozoites; Parasitemia; Plasmodium falciparum; Protozoan Proteins | 2009 |
Plasmodium berghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Drug Synergism; Drug Therapy, Combination; Malaria; Male; Mice; Mice, Inbred ICR; Orotic Acid; Parasitemia; Plasmodium berghei; Pyrimethamine | 2009 |
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Female; Follow-Up Studies; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Sensitivity and Specificity; Time Factors; Vietnam; Young Adult | 2010 |
Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Clinical Protocols; Colombia; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Plasmodium falciparum; Primaquine; Treatment Outcome | 2010 |
Combined intravenous treatment with artesunate and quinine for severe malaria in Italy.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intravenous; Italy; Malaria, Falciparum; Male; Parasitemia; Quinine; Retrospective Studies; Travel | 2010 |
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain; Leukocytes; Malaria, Cerebral; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Quinine | 2011 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
Automated erythrocytapheresis for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Australia; Automation; Blood Component Removal; Cambodia; Combined Modality Therapy; Drug Therapy, Combination; Erythrocyte Transfusion; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Travel | 2011 |
Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Ethiopia; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sentinel Surveillance; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Artesunate for severe malaria in African children.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Bacteremia; Child; Child, Preschool; Humans; Malaria; Parasitemia; Severity of Illness Index | 2011 |
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sex Factors; Thailand; Time Factors; Treatment Outcome; Young Adult | 2011 |
The antiplasmodial activity of Anogeissus leiocarpus and its effect on oxidative stress and lipid profile in mice infected with Plasmodium bergheii.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Combretaceae; Disease Models, Animal; Lipids; Liver; Malaria; Mice; Oxidative Stress; Parasitemia; Plant Bark; Plant Extracts; Plasmodium berghei; Superoxide Dismutase; Treatment Outcome | 2012 |
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Female; Fluorenes; Hospitals, Urban; Humans; Lumefantrine; Malaria; Malaysia; Microscopy; Middle Aged; Parasitemia; Patient Selection; Plasmodium knowlesi; Polymerase Chain Reaction; Quinine; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Survival Rate | 2011 |
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.
Topics: Antimalarials; Artemisinins; Artesunate; Blood; Cambodia; Humans; Malaria, Falciparum; Parasite Load; Parasitemia; Plasmodium falciparum | 2011 |
Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.
Topics: Antimalarials; Artemisinins; Artesunate; Female; Germany; Hemolysis; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Travel; Young Adult | 2012 |
Acute pancreatitis in a case of falciparum malaria--a rare presentation.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Humans; Malaria, Falciparum; Male; Multiple Organ Failure; Pancreatitis; Parasitemia; Plasmodium falciparum; Severity of Illness Index; Tomography, X-Ray Computed | 2011 |
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Parasitemia | 2012 |
Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Treatment Outcome | 2012 |
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Retrospective Studies; Thailand; Time Factors; Treatment Outcome; Young Adult | 2012 |
A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Malaysia; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Plasmodium knowlesi; Plasmodium vivax; Prospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2013 |
Editorial commentary: single-dose primaquine as gametocytocidal treatment in patients with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum | 2013 |
MDR1-associated resistance to artesunate+mefloquine does not impair blood-stage parasite fitness in a rodent malaria model.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Disease Models, Animal; Drug Resistance; Host-Pathogen Interactions; Male; Mice; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium chabaudi; Protozoan Proteins | 2013 |
Efficacy comparison of intravenous artelinate and artesunate in Plasmodium berghei-infected Sprague-Dawley rats.
Topics: Animals; Artemisinins; Artesunate; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Malaria; Male; Parasitemia; Plant Extracts; Plasmodium berghei; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Time Factors | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Malaria, Falciparum; Male; Mice; Parasitemia; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Proguanil; Sesquiterpenes; Triazines | 2004 |
The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Proguanil; Rodent Diseases; Sesquiterpenes | 2005 |
Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
Topics: Animals; Antimalarials; Aotidae; Artemether; Artemisinins; Artesunate; Benzamidines; Chloroquine; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Malaria, Vivax; Parasitemia; Peroxides; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes; Spiro Compounds; Time Factors | 2006 |
New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Malaria; Maximum Tolerated Dose; Parasitemia; Plasmodium berghei; Prodrugs; Pyrroles; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Therapeutic Equivalency | 2006 |
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Polymerase Chain Reaction; Sesquiterpenes; Sierra Leone; Treatment Outcome | 2006 |
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
Topics: Africa South of the Sahara; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Topics: Administration, Rectal; Adolescent; Adult; Africa; Aging; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Child; Child, Preschool; Demography; Female; Humans; Infant; Malaria; Male; Middle Aged; Parasitemia; Salvage Therapy; Sesquiterpenes; Sex Factors; Suppositories; Treatment Outcome | 2006 |
Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Immunoglobulin G; Interferon-gamma; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Parasitemia; Plasmodium yoelii; Recurrence; Sesquiterpenes | 2007 |
The risk of malarial infections and disease in Papua New Guinean children.
Topics: Adolescent; Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; DNA, Protozoan; Female; Humans; Incidence; Longitudinal Studies; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Risk Factors; Rural Population; Sesquiterpenes | 2007 |
Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children.
Topics: Adolescent; Amino Acid Sequence; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Haplotypes; Humans; Malaria, Vivax; Papua New Guinea; Parasitemia; Phylogeny; Plasmodium vivax; Polymorphism, Genetic; Protozoan Proteins; Receptors, Cell Surface; Sesquiterpenes | 2007 |
Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
Topics: Adult; Animals; Artemisinins; Artesunate; Blood; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Schizonts; Sesquiterpenes; Thailand; Trophozoites | 2008 |
The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Synergism; Malaria; Male; Mice; Parasitemia; Peroxides; Plasmodium; Plasmodium berghei; Plasmodium yoelii; Sesquiterpenes; Spiro Compounds | 1997 |
Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories.
Topics: Absorption; Antimalarials; Artemisinins; Artesunate; Child; Female; Fever; Gabon; Humans; Malaria, Falciparum; Male; Parasitemia; Sesquiterpenes; Suppositories | 1998 |
Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Humans; Immunoassay; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Kinetics; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Pilot Projects; Plasmodium falciparum; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1999 |
The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Erythrocytes; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Quinine; Sesquiterpenes | 2000 |
Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Humans; Malaria, Falciparum; Models, Biological; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Cost-Benefit Analysis; Disease Transmission, Infectious; Drug Combinations; Female; Gambia; Gametogenesis; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Random Allocation; Rural Health; Seasons; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2001 |
Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Models, Biological; Parasitemia; Plasmodium; Sesquiterpenes | 2002 |
Central role of the spleen in malaria parasite clearance.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Erythrocytes; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes; Spleen; Splenectomy | 2002 |